Get Started
Multiple Sclerosis Curricula
Step 1

The Advanced Certificate Program in
Multiple Sclerosis Management III
  1. Course List
Search by

Currently Available

Course Title Faculty Release Date
Expert Insight Into: An Oral Immunomodulator in Patients with RRMS (Part 12 of Series)Article Review (MS03.19) 1996.12 Lisak May 2011
Highlights of the American Academy of Neurology Annual MeetingPodcast Series (MS03.18) 1998.02 Bowen
Apr 2011
Expert Insight Into: A Phosphodiesterase Inhibitor in RRMS - €“A Neuroprotectant? (Part 11 of Series)Article Review (MS03.17) 1996.11 Lublin Apr 2011
Expert Insight Into: Ocular Pathology in Multiple Sclerosis - €”Retinal Atrophy and Inflammation Irrespective of Disease Duration (Part 10 of Series)Article Review (MS03.16) 1996.10 Cross Mar 2011
Case Study: Pregnancy Considerations in an MS PatientTx Reporter e-Newsletter (MS03.15) 1997.04 Lublin
Feb 2011
Expert Insight Into: T Helper Type 1 and 17 Cells Determine Efficacy of Interferon-beta in Multiple Sclerosis and Experimental Encephalomyelitis (Part 9 of Series)Article Review (MS03.14) 1996.09 Dhib-Jalbut Feb 2011
Risk Factors in MS: Nature Versus NurturePodcast Series (MS03.12) 1999 Miller
Jan 2011
Expert Insight Into: Neuromyelitis Optica in France: A Multicenter Study of 125 Patients (Part 8 of Series)Article Review (MS03.13) 1996.08 DeAngelis Jan 2011
Expert Insight Into: Genome, Epigenome and RNA Sequences of Monozygotic Twins Discordant for Multiple Sclerosis (Part 7 of Series)Article Review (MS03.10) 1996.07 Lisak Dec 2010
Case Study: Black Teenager with MSTx Reporter e-Newsletter (MS03.11) 1997.03 Miller
Dec 2010
Expert Insight Into: MRI Criteria for MS in Patients with Clinically Isolated Syndromes (Part 6 of Series)Article Review (MS03.08) 1996.06 Inglese Nov 2010
Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual MeetingPodcast Series (MS03.09) 1998.01 Lublin
Oct 2010
Expert Insight Into: Evidence Report: The Efficacy and Safety of an Immunosuppressant in the Treatment of Multiple Sclerosis (Part 5 of Series)Article Review (MS03.07) 1996.05 DeAngelis Oct 2010
Expert Insight Into: Multiple Sclerosis - €”Distribution of Inflammatory Cells in Newly Forming Lesions (Part 4 of Series)Article Review (MS03.06) 1996.04 Dhib-Jalbut Sep 2010
Case Study: Development of Neurologic Symptoms in a Patient Treated with Disease Modifying Monoclonal Antibody TherapyTx Reporter e-Newsletter (MS03.05) 1997.02 Lublin
Aug 2010
Expert Insight Into: A Prospective Open-Label Study of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (Part 3 of Series)Article Review (MS03.04) 1996.03 Cross Aug 2010
Case Study: SPMS with Walking Impairment and Paroxysmal Dysarthria Tx Reporter e-Newsletter (MS03.03) 1997.01 Miller
Jul 2010
Expert Insight Into: A Placebo-Controlled Trial of an Oral Immunomodulator in Relapsing Multiple Sclerosis (Part 2 of Series) Article Review (MS03.02) 1996.02 Lublin Jul 2010
Expert Insight Into: The Natural History of Primary Progressive Multiple Sclerosis (Part 1 of Series)Article Review (MS03.01) 1996.01 Miller Jun 2010